Clinical Trial Update: Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating isolated hepatic perfusion in combination with ipilimumab and nivolumab for metastatic uveal melanoma to the liver; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Metastases
• Uveal Melanoma

Drugs mentioned

• OPDIVO (nivolumab)
• Yervoy (ipilimumab)

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Uveal Melanoma, Liver Metastases | Phase 1 | Status: COMPLETED